BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10023645)

  • 1. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
    Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
    Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ascitic level of hyaluronan in liver cirrhosis.
    Lai KN; Szeto CC; Lam CW; Lai KB; Wong TY; Leung JC
    J Lab Clin Med; 1998 Apr; 131(4):354-9. PubMed ID: 9579389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
    Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis.
    Szeto CC; Wong TY; Lai KB; Lam CW; Lai KN; Li PK
    Am J Kidney Dis; 2000 Sep; 36(3):609-14. PubMed ID: 10977794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis.
    Breborowicz A; Wisniewska J; Polubinska A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
    Perit Dial Int; 1998; 18(4):382-6. PubMed ID: 10505559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
    Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
    Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD.
    Yung S; Coles GA; Davies M
    Kidney Int; 1996 Oct; 50(4):1337-43. PubMed ID: 8887296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
    Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
    Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA.
    Witowski J; Jörres A; Coles GA; Williams JD; Topley N
    Kidney Int; 1996 Oct; 50(4):1212-23. PubMed ID: 8887280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a high peritoneal transport rate reflect a state of chronic inflammation?
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Perit Dial Int; 1999; 19(1):17-22. PubMed ID: 10201336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The source and possible significance of hyaluronan in the peritoneal cavity.
    Yung S; Coles GA; Williams JD; Davies M
    Kidney Int; 1994 Aug; 46(2):527-33. PubMed ID: 7967367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients.
    Yamagata K; Tomida C; Koyama A
    Perit Dial Int; 1999; 19(2):131-7. PubMed ID: 10357183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
    Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of peritoneal membrane function in continuous ambulatory peritoneal dialysis: relationship with peritonitis and fibrosing factors.
    Wong TY; Szeto CC; Lai KB; Lam CW; Lai KN; Li PK
    Perit Dial Int; 2000; 20(6):679-85. PubMed ID: 11216559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages.
    Sach M; Bauermeister K; Burger JA; Loetscher P; Elsner J; Schollmeyer P; Dobos GJ
    Nephrol Dial Transplant; 1997 Feb; 12(2):315-20. PubMed ID: 9132652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
    Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG
    Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.